Literature DB >> 20789564

Effect of Desferrioxamine and D.T.P.A. in Iron Overload.

R M Bannerman, S T Callender, D L Williams.   

Abstract

Entities:  

Year:  1962        PMID： 20789564      PMCID： PMC1926807          DOI： 10.1136/bmj.2.5319.1573

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  The determination of iron in plasma or serum.

Authors:  T H BOTHWELL; B MALLETT
Journal:  Biochem J       Date:  1955-04       Impact factor: 3.857

2.  Iron excretion in thalassaemia major after administration of chelating agents.

Authors:  R S SMITH
Journal:  Br Med J       Date:  1962-12-15

3.  The role of splenectomy in the management of thalassemia.

Authors:  C H SMITH; M E ERLANDSON; G STERN; I SCHULMAN
Journal:  Blood       Date:  1960-02       Impact factor: 22.113

4.  Evaluation of trisodium calcium diethylenetriaminepentacetate in iron storage disease.

Authors:  J L FAHEY; C E RATH; J V PRINCIOTTO; I B BRICK; M RUBIN
Journal:  J Lab Clin Med       Date:  1961-03

5.  [On iron-containing growth factors, sideramines, and their antagonists, the iron-containing antibiotics, sideromycins].

Authors:  H BICKEL; E GAEUMANN; W KELLER-SCHIERLEIN; V PRELOG; E VISCHER; A WETTSTEIN; H ZAEHNER
Journal:  Experientia       Date:  1960-04-15

6.  Absorption of haemoglobin iron.

Authors:  S T CALLENDER; B J MALLETT; M D SMITH
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

7.  N-hydroxyethylethylenedianine triacetic acid, versenol, in the treatment of hemochromatosis.

Authors:  M J SEVEN; H GOTTLIEB; H L ISRAEL; J G REINHOLD; M RUBIN
Journal:  Am J Med Sci       Date:  1954-12       Impact factor: 2.378

8.  Transfusion hemosiderosis; report of a case treated with BAL.

Authors:  W T OHLSSON; G T KULLENDORFF; L K LJUNGBERG
Journal:  Acta Med Scand       Date:  1953

9.  Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders.

Authors:  R L HUFF; T G HENNESSY; R E AUSTIN; J F GARCIA; B M ROBERTS; J H LAWRENCE
Journal:  J Clin Invest       Date:  1950-08       Impact factor: 14.808

10.  Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.

Authors:  S C FINCH; C A FINCH
Journal:  Medicine (Baltimore)       Date:  1955-12       Impact factor: 1.889
  10 in total
  14 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

2.  DESFERRIOXAMINE-B.

Authors:  P WOOD
Journal:  Br Med J       Date:  1963-11-30

3.  TO-DAY'S DRUGS. DESFERRIOXAMINE B MESYLATE.

Authors:  E WHETNALL
Journal:  Br Med J       Date:  1965-02-06

Review 4.  IRON DEFICIENCY AND IRON OVERLOAD.

Authors: 
Journal:  Arch Dis Child       Date:  1965-08       Impact factor: 3.791

5.  Iron Overload.

Authors: 
Journal:  Br Med J       Date:  1963-01-12

6.  [Possible side-effects of antidotal therapy].

Authors:  W Wirth
Journal:  Arch Toxikol       Date:  1968

7.  Acute iron poisoning in children: role of chelating agents.

Authors:  D G Barr; D K Fraser
Journal:  Br Med J       Date:  1968-03-23

8.  Desferrioxamine in thalassaemia.

Authors:  M Diwany; M Gabr; A el Hefni; N Mokhtar
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

9.  Nature of anaemia in rheumatoid arthritis. VII. Storage of iron in rheumatoid disease.

Authors:  A A Lawson; E T Owen; A G Mowat
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

10.  Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.

Authors:  J Fielding; M C O'Shaughnessy; G M Brunström
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.